Nevirapine / rifampicin interaction linked to higher recurrence of TB in people on ART
TB still killing 4000 people with HIV each day, WHO reports
Managing MDR-TB in the community: from presentation to cure or end-of-life care
Decentralised, patient-centred models of delivering treatment and palliative care for people with M/XDR-TB
Patients taking TB treatment may be potentially infectious for longer than previously thought
Starting ART two weeks after TB treatment reduces death risk by one-third in people with HIV
Timing of ART initiation during TB treatment may not have significant impact on risk of death
HIV & TB in Practice: Improving clinical management of TB in people with HIV
Collaborative TB and HIV services for drug users
